Joan Lunden Discusses Her TNBC Diagnosis With Roy Firestone

Joan Lunden
Published: Thursday, Jan 22, 2015



Joan Lunden discusses the diagnostic approach that led to the early detection of triple-negative breast cancer, which was undetected by mammogram and 3D mammogram but was detected with ultrasound.

Lunden recounts an interview with Susan M. Love, MD, where she discovered the need for ultrasound, as a result of her dense breast tissue. It was this revelation and procedure that greatly impacted the stage of disease at diagnosis and overall prognosis, Lunden states.

Joan Lunden will be delivering the keynote address at the 32nd Miami Breast Cancer Conference. To attend the meeting along with OncLive, register at gotoper.com.



Joan Lunden discusses the diagnostic approach that led to the early detection of triple-negative breast cancer, which was undetected by mammogram and 3D mammogram but was detected with ultrasound.

Lunden recounts an interview with Susan M. Love, MD, where she discovered the need for ultrasound, as a result of her dense breast tissue. It was this revelation and procedure that greatly impacted the stage of disease at diagnosis and overall prognosis, Lunden states.

Joan Lunden will be delivering the keynote address at the 32nd Miami Breast Cancer Conference. To attend the meeting along with OncLive, register at gotoper.com.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
Community Practice Connections: Oncology Best Practice™ Targeting Cell Cycle Progression: The Latest Advances on CDK4/6 Inhibition in Metastatic Breast CancerOct 31, 20181.0
Publication Bottom Border
Border Publication
x